
Lupin Launches Authorized Generic Version Of Ravicti® In The United States For Urea Cycle Disorder Management
Mumbai: Global pharmaceutical major Lupin Limited announced the launch of an authorized generic version of Ravicti® (Glycerol Phenylbutyrate) Oral Liquid, 1.1g/mL, in the













